Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Reexamination Certificate
2006-06-13
2006-06-13
Saucer, Sandra E. (Department: 1651)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
C424S756000
Reexamination Certificate
active
07060733
ABSTRACT:
Disclosed are methods of treating, preventing, modulating, attenuating, or inhibiting a disease or a disorder associated with inflammation related to NF-κB activation in a subject which comprises administering to the subject at least one curcumin compound. Also disclosed are combination therapies comprising the administration of at least one curcumin compound and at least one ROS inhibitor. Pharmaceutical compositions and kits are also disclosed.
REFERENCES:
patent: 5401777 (1995-03-01), Ammon et al.
Lee, J-I, et al. 1998. Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol 38: 981-993.
Surh, Y-J, et al. 2001. Molecular mechanisms underlying chemoprotective activities of anti-inflammatory phytochemicals: downregulation of COX-2 and iNOS through suppression of NF-kB activation. Mut. Res. 480-481: 243-268.
Sakurada, S, et al. 1996. Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblast and inhibition by N-acetyl-L-cysteine and aspirin. Int. Immunol. 8: 1483-1493.
Catella-Lawson, F, et al. 2001. Cyclooxygenase inhibition and thrombogenicity. Am J Med 110: 28S-32S.
Gukovsky, I, et al. 1998. Early NF-kB activation is associated with hormone-induced pancreatitis. Am J Physiol 247: G1402-1414.
Bagshawe, K. (1995) “Antibody-Directed Enzyme Prodrug Therapy: A Review” Drug Development Research, 34:220-230.
Topazian, M. and Gorelick, F. “Acute Pancreatitis” Pathophysiology, Chapter 93, pp. 2121-2150. No Pub Date.
Owyang, C. “Chronic Pancreatitits” Etiology, Chapter 94, pp. 2151-2177. No Pub Date.
Pandol, S., et al. (1999) “Ethanol Diet Incsreases the Sensitivity of Rats to Pancreatitis Induced by Cholecystokinin Octapeptide” Gastroenterology, 117:706-716.
Vaquero, E., et al. (2001) “Localized Pancreatic NF-κB Activation and Inflammatroy Response in Taurocholate-induced Pancreatitis” Am J. Physiol Gastrointest Liver Physiol., 280:G1197-G1208.
Vaquero, E. et al. (1999) “Myofibroblast Proliferation, Fibrosis, and Defective Pancreatic repair Induced by Cyclosporin in Rats” Gut, 45:269-277.
Bhatia, M., et al. (1999) “Inflammatory Mediators in Acute Pancreatitis” Journal of Pathology, 190:117-125.
Norman, J. (1998) “The Role of cytokines in the Pathogenesisi of Acute Pancreatitis” The American Journal of Surgery, 175:76-83.
Schmid, R and Adler, G. (1998) “Cytokines in Acute Pancratitis—New Pathophysiological Concepts Evolve” European Journal of Gastroenterology & Hepatology, 11(2):125-127.
Gukovsky, I. et al. (1998) “Early NF-κB Activation is Associated With Hormone-induced Pancreatitis” American J. Physiol., 275:G1402-G1414.
Blinman, T., et al. (2000) “Activation of Pancreatic Acinar Cells on Isolation From Tissue: Cytokine Upregulation Via p38 MAP Kinase” Am J. Physiol Cell Physiol, 279:C1993-C2003.
Frossard, J., et al. (1999) “The Role of Intercellular Adhesion Molecule 1 and Neutrophils in Acute Pancreatitis and Pancreatitis-Associated Lung Injury” Gastroenterology, 116:694-701.
Gukovskaya, A., et al. (1997) “Pancreatic Acinar Cells Produce, Release, and Respond to Tumor Necrosis Factor-α Role in Regulating Cell Death and Pancreatitis” Journal of Clinical Investigation, 100(7):1853-1862.
Han, B. and Logsdon, C. (1999) “Cholecystikinin Induction ofmob-lChemokine Expression in Pancreatic Acinar Cells Requires NF-κB Activation” American J. Physiol. 277:C74-C82.
Zaninovic, V., et al. (2000) “Cerulein Upregulated ICAM-1 in Pancreatic Acinar Cells, Which Mediates Neutrophil Adhesion to These Cells” Am J Physiol Gastrointest Liver Physiol, 279:G666-G676.
Sandoval D., et al. (1996) “the Role of Neutrophils and Platelet-Activating Factor in Mediating Experimental Pancreatitis” Gastroenterology, 111:1081-1091.
Tartaglia, L. and Goeddel, D. (1992) “Two TNF Receptors” Immunology Today, 13(5):151-153.
Hohmann, H., et al. (1990) “Expression of the Types A and B Tumor Necrosis Factor (TNF) Receptors is Independently Regulated, and Both Receptors Mediate Activation of the Transcription Factor NF-κB” Journal of Biological Chemistry, 265:36: 22409-22417.
Barnes et al. (1997) “Nuclear Factor-κB—A Pivotal Transcription Factor in Chronic Inflammatory Diseases” New England Journal of Medicine, 336:15:1066-1071.
Ben-Baruch A. et al. (1995) “Signals and Receptors Involved in Recruitment of Inflammatory Cells” Journal of Biological Chemistry, 270(20):11701-11706.
Beauparlant, P. and Hiscott J. (1996) “Biological and Biochemical Inhibitors of the NF-κB/Rel Proteins and Cytokine Synthesis” Cytokine & Growth Factor Reviews, 7(2):175-190.
Van Antwerp. D., et al. (1996) “Suppression of TNF-α-Induced Apoptosis by NF- κB” Science, 274:787-789.
Wang, C., et al. (1996) “TNF-and Cancer Therapy-Induced apoptosis: Potentiation by Inhibition of NF- κB” Science, 274:784-787.
Sen, R. and Baltimore D. (1986) “Multiple Nuclear Factors Interact with the Immunoglobulin Enhancer Sequences” Cell, 46:705-716.
Verma, I., et al. (1995) “Rel/NF- κB/I κB Family: Intimate Tales of Association and Dissociation” Genes & Development, 9:2723-2735.
Wulczyn, G. (1996) “The NF- κB/Rel and I κB Gene Families: Mediators of Immune Response and Inflammation” J. Mol. Med. 74(12):749-769.
DiDonato J., et al. (1996) “Mapping of the Inducible IκB Phosphorylation Sites That Signal Its Ubiquitination and Degradation” Molecular and Cellular Biology, 16(4):1295-1304.
Flohe, L., et al. (1997) “Redox Regulation of NF-Kappa B Activation” Free Radical Biology & Medicine, 22(6):115-1126.
Schreck R. and Baeuerle P. (1994) “Assessing Oxygen Radicals as Mediators in Activation of Inducible Eukaryotic Transcription Factor NF-κB” Methods in Enzymology, 234:151-163.
Karin, M., et al. (1997) “AP-1 Function and Regulation” Current Opinion in Cell Biology, 9:240-246.
Sluss, H., et al. (1994) “Signal Transduction by Tumor Necrosis Factor Mediated by JNK Protein Kinases” Molecular and Cellular Biology, 14(12):8376-8384.
Brenner, D., et al. (1989) “Prolonged Activation of Jun and Collagenase Genes by Tumour Necrosis Factor-α” Nature, 337:661-663.
Whitmarsh and Davis (1996) “Transcription Factor AP-1 Regulation by Mitogen-Activated Protein Kinase Signal Transduction Pathways” J. Mol. Med. 74(10):589-607.
Westwick J., et al. (1994) “Tumor Necrosis Factor α Stimulates AP-1 Activity Through Prolonged Activation of the c-June Kinase” Journal of Biological Chemistry, 269:42:26369-26401.
Singh and Aggarwal (1995) “Activation of Transcription Factor NF- κB Is Suppressed by Curcumin (Diferulolylmethane)” J. Biol. Chem. 270(42):24995-25000.
Pendurthi, U., et al. (1997) “Inhibition of Tissue Factor Gene Activation in Cultured Endothelial Cells by Curcumin” Arteriosclerosis, Thrombosis, and Vascular Biology, 17:3406-3413.
Luo, Y., et al. (1999) “IntrastriatalDopamine Injection Induces Apoptosis Through Oxidation-Involved Activation of Transcription Factors AP-1 and NF- κB in Rats” Molecular Pharmacology, 56:254-264.
Soler, A. et al. (1999) “Activation of NF- κB is Necessary for the Restoration of the Barrier Function of an Epithelium Undergoing TNF-α-induced Apoptosis” European Journal of Cell Biology, 78:56-66.
Jobin, C., et al. (1999) “Curcumin Blocks Cytokine-Mediated NF- κB Activation and Proinflammatory Gene Expression by Inghibiting Inhibitory Factor I- κB Kinase Activity” J. of Immunol., 163(6):3474-3483.
Pan, M., et al. (2000) “Comparative Studies on the Suppressi
Gukovsky Ilya Y.
Pandol Stephen J.
Barnhart Lora E
Saucer Sandra E.
Smith , Gambrell & Russell, LLP
Sundby, Esq. Suzannah K.
The Regents of the University of California
LandOfFree
Methods for treating pancreatitis with curcumin compounds... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating pancreatitis with curcumin compounds..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating pancreatitis with curcumin compounds... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3662859